Skip to content

Lidocaine Spray for Pain Control during Office-based Endometrial Biopsy: A Randomised Placebo-controlled Trial

Lidocaine Spray for Pain Control during Office-based Endometrial Biopsy: A Randomised Placebo-controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170714001
Enrollment
Unknown
Registered
2017-07-14
Start date
2016-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormal uterine bleeding lidocaine&#44

Interventions

lidacaine spray 5 puff at cervical for pain control during endometrial biopsy,sterile water 5 puff at cervical
Placebo Comparator Drug,Placebo Comparator Drug
Lidocaine spray for pain control,placebo

Sponsors

Research Facilitation Division, Faculty of Medicine Vajira hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -female up to 18 year old and accepted -Indication for endometrial sampling - no history of allergy for lidacaine

Exclusion criteria

Exclusion criteria: 1.allergy lidocaine 2.not accepted to participate research 3. active uterine bleeding 4. cervical pathology 5. uterine anomaly 5. active liver disease

Design outcomes

Primary

MeasureTime frame
Pain score during and after endometrial biopsy 10 cm-Visual analog scale

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactPawee Korsuwan

Faculty of Medicine, Vajira Hospital, Navamindradhiraj University

oatpawee@gmail.com02-244-3000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026